Vunakizumab
Product Specifications
CAS Number
1792181-33-9
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
1
Bioactivity
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a human IgGκ monoclonal antibody that specifically targets and inhibits IL-17A's receptor interaction, making it useful for researching autoimmune conditions such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B2064 96 Tests
Acetylcholine Receptor subunit epsilon (CHRNE) Human ELISA Kit
Sign In for Pricing
View Details 
158294 5 mg
1- (5-Fluoropentyl) -N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide
Sign In for Pricing
View Details